Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05629585 |
|---|---|
| Brief Title: | A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) |
| First Submitted : | November 4, 2022 |
| First Submitted that Met QC Criteria : | November 17, 2022 |
| First Posted : | November 29, 2022 |
| Last Update Submitted that Met QC Criteria : | March 22, 2023 |
| Last Update Posted : | March 23, 2023 |